| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 1,597 | $25.00 | $39,925.00 | -0.6% | -10.4% | -28.6% | |
| Mar 11, 2025 | PDEX Pro Dex Inc | Cabillot Raymond E66 | Director, 10% Owner | Sell | 12,806 | $45.02 | $576,577.92 | -2.0% | -13.7% | -4.4% | |
| Mar 10, 2025 | NXGL Nexgel, Inc. | Henry Scott Robert72 | Director | Sell | 3,000 | $2.87 | $8,621.10 | -2.1% | -15.6% | -66.3% | |
| Mar 10, 2025 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $230.36 | $230,360.00 | -1.1% | +6.1% | +4.4% | |
| Mar 10, 2025 | ATEC Alphatec Holdings, Inc. | Koning John Todd54 | Chief Financial Officer | Sell | 165,121 | $9.72 | $1,604,976.12 | -25.5% | +23.3% | +29.4% | |
| Mar 10, 2025 | EW Edwards Lifesciences Corp | Lippis Daniel J.62 | Cvp, Japac | Sell | 400 | $69.48 | $27,792.00 | -1.7% | +11.4% | +25.2% | |
| Mar 10, 2025 | DXR Daxor Corp | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 3,360 | $7.68 | $25,804.80 | +1.6% | +19.4% | +48.2% | |
| Mar 10, 2025 | RMD Resmed Inc | Ghoshal Kaushik64 | Chief Commercial Officer, Saas | Sell | 9,745 | $239.31 | $2,332,096.41 | -50.1% | +6.1% | +4.4% | |
| Mar 10, 2025 | MASI Masimo Corp | Muhsin Bilal | Chief Operating Officer | Sell | 30,000 | $167.49 | $5,024,585.10 | -9.3% | +3.9% | +6.1% | |
| Mar 10, 2025 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 1,000 | $8.00 | $8,000.00 | +6.2% | +19.4% | +48.2% | |
| Mar 10, 2025 | ATEC Alphatec Holdings, Inc. | Lish Scott60 | Chief Operating Officer | Sell | 27,994 | $9.72 | $272,101.68 | -3.3% | +23.3% | +29.4% | |
| Mar 10, 2025 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 38,000 | $1.81 | $68,780.00 | +77.1% | +30.5% | +11.3% | |
| Mar 10, 2025 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | CEO | Sell | 6,164 | $69.51 | $428,447.93 | -9.4% | +11.4% | +25.2% | |
| Mar 10, 2025 | BRKR Bruker Corp | Bures Thomas | Chief Accounting Officer | Buy | 500 | $47.40 | $23,697.50 | +16.8% | -17.3% | -22.8% | |
| Mar 10, 2025 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP, Chief Financal Officer | Sell | 7,000 | $73.83 | $516,830.28 | -1.7% | +21.2% | -4.1% | |
| Mar 7, 2025 | ISRG Intuitive Surgical Inc | Brosius Mark56 | SVP &Chief Mfg And Supply Cha | Sell | 489 | $533.18 | $260,725.02 | -19.0% | +7.7% | -5.4% | |
| Mar 7, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner76 | Chief Information Officer | Sell | 3,874 | $4.16 | $16,115.84 | -3.1% | -63.0% | -55.3% | |
| Mar 7, 2025 | RMD Resmed Inc | Farrell Michael J.62 | Chief Executive Officer | Sell | 8,009 | $229.20 | $1,835,692.43 | -1.7% | +7.4% | +8.8% | |
| Mar 7, 2025 | KMTS Kestra Medical Technologies, Ltd. | Cohen Raymond W | Director | Buy | 17,000 | $17.00 | $289,000.00 | +130.8% | -4.9% | +9.6% | |
| Mar 7, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 4,818 | $4.12 | $19,850.16 | -1.5% | -63.0% | -55.3% | |
| Mar 7, 2025 | TNDM Tandem Diabetes Care Inc | Kyrillos Jean-Claude | EVP &Chief Operating Officer | Buy | 10,538 | $18.12 | $190,966.47 | New | +15.0% | +17.7% | |
| Mar 7, 2025 | CERS Cerus Corp | Jensen Chrystal71 | Chief Legal Officer | Sell | 27,457 | $1.50 | $41,130.59 | -3.2% | -8.6% | +28.5% | |
| Mar 7, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 29,722 | $4.12 | $122,454.64 | -3.3% | -63.0% | -55.3% | |
| Mar 7, 2025 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 26,139 | $1.50 | $39,156.22 | -3.4% | -8.6% | +28.5% | |
| Mar 7, 2025 | CERS Cerus Corp | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 33,999 | $1.50 | $50,930.50 | -2.2% | -8.6% | +28.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.